Back
Oramed Pharmaceuticals, Inc. 10K Form
Sell
48
ORMP
Oramed Pharmaceuticals, Inc.
Last Price:
$2.73
Seasonality Move:
22.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | ORMP/Oramed Pharmaceuticals, Inc. Quarterly |
| 2023-11-09 | 10Q | ORMP/Oramed Pharmaceuticals, Inc. Quarterly |
| 2023-08-10 | 10Q | ORMP/Oramed Pharmaceuticals, Inc. Quarterly |
| 2023-05-11 | 10Q | ORMP/Oramed Pharmaceuticals, Inc. Quarterly |
| 2022-11-10 | 10Q | ORMP/Oramed Pharmaceuticals, Inc. Quarterly |
| 2022-08-10 | 10Q | ORMP/Oramed Pharmaceuticals, Inc. Quarterly |
Receive ORMP News And Ratings
See the #1 stock for the next 7 days that we like better than ORMP
ORMP Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.98 |
| Price / Book: | 0.53 |
Profitability
| EPS (TTM): | 1.00270 |
|---|---|
| Net Income (TTM): | $43.8M |
| Gross Margin: | $-193K |
| Return on Equity: | 27.49% |
| Return on Assets: | 25.77% |
Oramed Pharmaceuticals, Inc. Earnings Forecast
Key Oramed Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 21 years have been positive in 8 years.
Oramed Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ORMP |
| CUSIP: | 68403P |
| Website: | oramed.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 22.25 |
| Quick Ratio: | 22.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 16.43 |
|---|---|
| Forward P/E Ratio: | 0 |
ORMP Technical Analysis vs Fundamental Analysis
Sell
48
Oramed Pharmaceuticals, Inc. (ORMP)
is a Sell
Is Oramed Pharmaceuticals, Inc. a Buy or a Sell?
-
Oramed Pharmaceuticals, Inc. stock is rated a SellThe current Oramed Pharmaceuticals, Inc. [ORMP] share price is $2.72. The Score for ORMP is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.